| Revenue growth | 18.5% YoY for Q4 FY26; 20% for full year FY26. |
|---|---|
| Margins | EBITDA margin at ~34-35%; seeing non-linear growth vs headcount. |
| Order book | Announced significant full platform deal with a mid-sized health system. |
| Demand visibility | Strong; 90% repeat revenue; top 10 clients have 5+ year vintage. |
| Management confidence | High confidence in 'True North' strategy and AI-driven competitive moat. |
Growth
FY26 revenue reached INR 3,193 cr (up 20%), EBITDA INR 1,091 cr (up 38%), and PAT INR 721 cr (up 48%).
Outlook
Targeting FY30 EBITDA of INR 3,000 cr; shifting TruBridge from COBOL to SQL; scaling MyCare Hub and Scribble Select AI.
Risks
Seasonal Q4 weakness in US healthcare; potential pricing deflation in commoditized point solutions; TruBridge integration and debt deleveraging.
Earnings Call filed with NSE, NSE: IKS. Summary written with AI assistance from the document.
Inventurus Knowledge Solutions Ltd: key numbers
- Share price
- ₹1,815.80
- Market cap
- ₹31,154 Cr
- Revenue (annual)
- ₹3,192 Cr
- Net profit (annual)
- ₹721.5 Cr
- P/E (TTM)
- 40.8×Sector 57.8×
- Promoter holding
- 63.72%+0.00% QoQ
- FII holding
- 8.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Inventurus Knowledge Solutions Ltd
All →Inventurus Knowledge Solutions Annual General Meeting
Inventurus Knowledge Solutions held its 20th Annual General Meeting on September 21, 2026, transacting ordinary and special business items, including amendments to its ESOP Plan 2022.
Inventurus Knowledge Solutions Management Change
Inventurus Knowledge Solutions announced the resignation of Chief Human Resources Officer Manisha Kadagathur. Ms. Amaris McComas will succeed her as the new CHRO effective September 5, 2026.
Inventurus Knowledge Solutions Earnings Call Transcript: Key Takeaways
IKS Health delivered strong 21% YoY revenue growth, yet the TrueBridge acquisition lowers margins to the 26-27% range temporarily.
Inventurus Knowledge Solutions Investor Presentation: Key Takeaways
IKS Health delivered strong Q1 FY27 results with Revenue of INR 8,936 mn and EBITDA margin of 33%. Strategy focuses on AI integration and expansion in US healthcare markets.
Inventurus Knowledge Solutions Q1 FY27 Results: Net Profit ₹193.7 Cr, Up 27.9% YoY
Inventurus Knowledge Solutions Ltd reported revenue from operations of ₹893.6 Cr (+20.7% YoY) and net profit of ₹193.7 Cr (+27.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹193.7 Cr · +27.9% YoY
Inventurus Knowledge Solutions Earnings Call: Key Takeaways
IKS Health delivered a strong FY26 with 20% revenue growth and significant margin expansion, though reported PAT was aided by one-time forex gains.